Page 53 - วารสารกรมการแพทย์แผนไทยฯ ปีที่ 14 ฉบับที่ 3

271

2011;25(6):838-43. 51. Hunt EJ, Lester CE, Lester EA, Tackett RL. Effect of St.
40. Elsas SM, Rossi DJ, Raber J, White G, Seeley CA, Gregory Johnûs wort on free radical production. Life Sci. 2001;
WL, et al. Passiflora incarnata L. (Passionflower) extracts 69(2):181-90.
elicit GABA currents in hippocampal neurons in vitro, and 52. Coleta M, Campos MG, Cotrim MD, Proenca da Cunha A.
show anxiogenic and anticonvulsant effects in vivo, varying Comparative evaluation of Melissa officinalis L., Tilia
with extraction method. Phytomedicine. 2010;17(12):940- europaea L., Passiflora edulis Sims. and Hypericum
9. perforatum L. in the elevated plus maze anxiety test.
41. Grundmann O, Wahling C, Staiger C, Butterweck V. Pharmacopsychiatry. 2001;34 Suppl 1:S20-1.
Anxiolytic effects of a passion flower (Passiflora incarnata 53. Kumar V, Jaiswal AK, Singh PN, Bhattacharya SK. Anxiolytic
L.) extract in the elevated plus maze in mice. Die activity of Indian Hypericum perforatum Linn: an experi-
Pharmazie. 2009;64(1):63-4. mental study. Indian J Exp Biol. 2000;38(1):36-41.
42. Grundmann O, Wang J, McGregor GP, Butterweck V. 54. Vandenbogaerde A, Zanoli P, Puia G, Truzzi C, Kamuhabwa
Anxiolytic activity of a phytochemically characterized A, De Witte P, et al. Evidence that total extract of
Passiflora incarnata extract is mediated via the GABAergic Hypericum perforatum affects exploratory behavior and
system. Planta Med. 2008;74(15):1769-73. exerts anxiolytic effects in rats. Pharmacol Biochem Behav.
43. Soulimani R, Younos C, Jarmouni S, Bousta D, Misslin R, 2000;65(4):627-33.
Mortier F. Behavioural effects of Passiflora incarnata L. 55. Beijamini V, Andreatini R. Effects of Hypericum perforatum
and its indole alkaloid and flavonoid derivatives and maltol and paroxetine on rat performance in the elevated T-maze.
in the mouse. J Ethnopharmacol. 1997;57(1):11-20. Pharmacological Research. 2003;48(2):199-207.
44. Aslanargun P, Cuvas O, Dikmen B, Aslan E, Yuksel MU. 56. Taylor LH, Kobak KA. An open-label trial of St. Johnûs
Passiflora incarnata Linneaus as an anxiolytic before spinal Wort (Hypericum perforatum) in obsessive-compulsive
anesthesia. J Anesth. 2012;26(1):39-44. disorder. J Clin Psychiatry. 2000;61(8):575-8.
45. Akhondzadeh S, Naghavi HR, Vazirian M, Shayeganpour 57. Kobak KA, Taylor LV, Warner G, Futterer R. St. Johnûs
A, Rashidi H, Khani M. Passionflower in the treatment of wort versus placebo in social phobia: results from a placebo-
generalized anxiety: a pilot double-blind randomized controlled pilot study. J Clin Psychopharmacol. 2005;
controlled trial with oxazepam. J Clin Pharm Ther. 2001; 25(1):51-8.
26(5):363-7. 58. Muller D, Pfeil T, von den Driesch V. Treating depression
46. Fisher AA, Purcell P, Le Couteur DG. Toxicity of Passiflora comorbid with anxiety-results of an open, practice-oriented
incarnata L. J Toxicol Clin Toxicol. 2000;38(1):63-6. study with St Johnûs wort WS 5572 and valerian extract
47. Gupta RK, Kumar D, Chaudhary AK, Maithani M, Singh R. in high doses. Phytomedicine. 2003;10 Suppl 4:25-30.
Antidiabetic activity of Passiflora incarnata Linn. in 59. Sarris J, Kavanagh DJ, Deed G, Bone KM. St. Johnûs
streptozotocin-induced diabetes in mice. J Ethnopharmacol. wort and Kava in treating major depressive disorder with
2012;139(3):801-6. comorbid anxiety: a randomised double-blind placebo-
48. Nathan PJ. Hypericum perforatum (St Johnûs Wort): a controlled pilot trial. Hum Psychopharmacol. 2009;24(1):41-
non-selective reuptake inhibitor? A review of the recent 8.
advances in its pharmacology. J Psychopharmacol. 60. Schulz HU, Schurer M, Bassler D, Weiser D. Investigation
2001;15(1):47-54. of the effect on photosensitivity following multiple oral
49. Thiede HM, Walper A. Inhibition of MAO and COMT by dosing of two different hypericum extracts in healthy men.
hypericum extracts and hypericin. J Geriatric Psychiatry Arzneimittel-Forschung. 2006;56(3):212-21.
Neurol. 1994;7 Suppl 1:S54-6. 61. Woelk H, Burkard G, Grunwald J. Benefits and risks of
50. Gobbi M, Moia M, Pirona L, Morizzoni P, Mennini T. In the hypericum extract LI 160: drug monitoring study with
vitro binding studies with two Hypericum perforatum 3250 patients. J Geriatric Psychiatry and Neurol. 1994;7
extracts-hyperforin, hypericin and biapigenin-on 5-HT6, 5- Suppl 1:S34-8.
HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors 62. Lee A, Minhas R, Matsuda N, Lam M, Ito S. The safety of
and dopamine transporters. Pharmacopsychiatry. 2001;34 St. Johnûs wort (Hypericum perforatum) during breast-
Suppl 1:S45-8. feeding. J Clin Psychiatry. 2003;64(8):966-8.